{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:10:31Z","timestamp":1777399831174,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["1R01CA138441"],"award-info":[{"award-number":["1R01CA138441"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["CA88184"],"award-info":[{"award-number":["CA88184"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"crossref","award":["RSGM-10-189-01-TBE"],"award-info":[{"award-number":["RSGM-10-189-01-TBE"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"crossref"}]},{"name":"FAMRI Young Investigator Award","award":["062438"],"award-info":[{"award-number":["062438"]}]},{"DOI":"10.13039\/100014039","name":"DOD Prostate Cancer Research Program","doi-asserted-by":"crossref","award":["W81XWH-07-01-0089"],"award-info":[{"award-number":["W81XWH-07-01-0089"]}],"id":[{"id":"10.13039\/100014039","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014039","name":"DOD Prostate Cancer Research Program","doi-asserted-by":"crossref","award":["W81XWH-08-1-0459"],"award-info":[{"award-number":["W81XWH-08-1-0459"]}],"id":[{"id":"10.13039\/100014039","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wisconsin Breast Cancer Showhouse"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.yexcr.2011.08.008","type":"journal-article","created":{"date-parts":[[2011,8,25]],"date-time":"2011-08-25T22:08:33Z","timestamp":1314310113000},"page":"2671-2682","source":"Crossref","is-referenced-by-count":41,"title":["The Raf\/MEK\/extracellular signal-regulated kinase 1\/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells"],"prefix":"10.1016","volume":"317","author":[{"given":"Seung-Keun","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Fong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-In","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2011.08.008_bb0005","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.bbamcr.2006.10.005","article-title":"The MEK\/ERK cascade: from signaling specificity to diverse functions","volume":"1773","author":"Shaul","year":"2007","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0010","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf\u2013MEK\u2013ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0015","first-page":"279","article-title":"Activation of mitogen-activated protein kinase associated with prostate cancer progression","volume":"59","author":"Gioeli","year":"1999","journal-title":"Cancer Research"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/hupa.2002.32227","article-title":"Regulation of proliferation\/apoptosis equilibrium by mitogen-activated protein kinases in normal, hyperplastic, and carcinomatous human prostate","volume":"33","author":"Royuela","year":"2002","journal-title":"Human Pathology"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0025","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pros.10212","article-title":"Differential expression and\/or activation of P38MAPK, erk1\/2, and jnk during the initiation and progression of prostate cancer","volume":"55","author":"Uzgare","year":"2003","journal-title":"The Prostate"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0030","first-page":"3051","article-title":"Targeting AKT\/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model","volume":"118","author":"Kinkade","year":"2008","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0035","first-page":"5991","article-title":"Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas","volume":"52","author":"Anwar","year":"1992","journal-title":"Cancer Research"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0040","first-page":"2789","article-title":"Mutations of ras genes are relatively frequent in Japanese prostate cancers: pointing to genetic differences between populations","volume":"18","author":"Shiraishi","year":"1998","journal-title":"Anticancer Research"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0045","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/ijc.22071","article-title":"BRAF and KRAS mutations in prostatic adenocarcinoma","volume":"119","author":"Cho","year":"2006","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cancergencyto.2009.12.003","article-title":"KRAS and BRAF mutations in prostate carcinomas of Chinese patients","volume":"198","author":"Shen","year":"2010","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0055","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm.2166","article-title":"Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma","volume":"16","author":"Palanisamy","year":"2010","journal-title":"Nature Medicine"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0898-6568(02)00115-8","article-title":"Nuclear receptors: integration of multiple signalling pathways through phosphorylation","volume":"15","author":"Rochette-Egly","year":"2003","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0065","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/er.2002-0032","article-title":"Androgen receptor in prostate cancer","volume":"25","author":"Heinlein","year":"2004","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0070","doi-asserted-by":"crossref","first-page":"e001","DOI":"10.1621\/nrs.06001","article-title":"AR, the cell cycle, and prostate cancer","volume":"6","author":"Balk","year":"2008","journal-title":"Nuclear Receptor Signaling"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1517\/14796694.1.1.91","article-title":"Targeting the androgen receptor in hormone-refractory prostate cancer\u2014new concepts","volume":"1","author":"Eder","year":"2005","journal-title":"Future Oncology (London, England)"},{"issue":"Suppl 2","key":"10.1016\/j.yexcr.2011.08.008_bb0080","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1093\/annonc\/12.suppl_2.S141","article-title":"Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status","volume":"12","author":"Bonkhoff","year":"2001","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0085","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1440-1827.2001.01226.x","article-title":"Prognostic significance of neuroendocrine differentiation, proliferation activity and androgen receptor expression in prostate cancer","volume":"51","author":"Segawa","year":"2001","journal-title":"Pathology International"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0090","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1677\/erc.0.0060503","article-title":"Neuroendocrine cells in tumour growth of the prostate","volume":"6","author":"Abrahamsson","year":"1999","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0095","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1677\/ERC-07-0061","article-title":"Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells","volume":"14","author":"Yuan","year":"2007","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/pros.20338","article-title":"Genetic analysis of neuroendocrine tumor cells in prostatic carcinoma","volume":"66","author":"Sauer","year":"2006","journal-title":"The Prostate"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0105","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1038\/sj.onc.1206764","article-title":"Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells","volume":"22","author":"Zhang","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/pros.20032","article-title":"Neuroendocrine cell differentiation in the CWR22 human prostate cancer xenograft: association with tumor cell proliferation prior to recurrence","volume":"60","author":"Huss","year":"2004","journal-title":"The Prostate"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0115","first-page":"741","article-title":"Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation","volume":"60","author":"Jongsma","year":"2000","journal-title":"Cancer Research"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0120","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1210\/me.2003-0031","article-title":"Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells","volume":"17","author":"Wright","year":"2003","journal-title":"Molecular Endocrinology (Baltimore Md)"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1677\/erc.1.01043","article-title":"Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells","volume":"13","author":"Yuan","year":"2006","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0130","doi-asserted-by":"crossref","first-page":"33006","DOI":"10.1074\/jbc.M109.012591","article-title":"Noncatalytic function of ERK1\/2 can promote Raf\/MEK\/ERK-mediated growth arrest signaling","volume":"284","author":"Hong","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0135","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1210\/endo.142.3.8049","article-title":"The androgen receptor (AR) amino-terminus imposes androgen-specific regulation of AR gene expression via an exonic enhancer","volume":"142","author":"Grad","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0140","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods (San Diego Calif)"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1475-2867-11-13","article-title":"Inverse baseline expression pattern of the NEP\/neuropeptides and NFkappaB\/proteasome pathways in androgen-dependent and androgen-independent prostate cancer cells","volume":"11","author":"Patrikidou","year":"2011","journal-title":"Cancer Cell International"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0150","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1074\/jbc.M608487200","article-title":"Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway is essential for neuroendocrine differentiation of prostate cancer","volume":"282","author":"Wu","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0155","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1128\/MCB.13.10.6241","article-title":"Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase","volume":"13","author":"Samuels","year":"1993","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0160","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1101\/gad.12.19.2997","article-title":"Senescence of human fibroblasts induced by oncogenic Raf","volume":"12","author":"Zhu","year":"1998","journal-title":"Genes & Development"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0165","doi-asserted-by":"crossref","first-page":"18871","DOI":"10.1074\/jbc.M011514200","article-title":"Dual growth arrest pathways in astrocytes and astrocytic tumors in response to Raf-1 activation","volume":"276","author":"Fanton","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0170","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1172\/JCI831","article-title":"Activated Raf-1 causes growth arrest in human small cell lung cancer cells","volume":"101","author":"Ravi","year":"1998","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0175","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1128\/MCB.23.2.543-554.2003","article-title":"The Ras\/Raf\/MEK\/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor\/JAK\/STAT pathway","volume":"23","author":"Park","year":"2003","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2010.04.021","article-title":"Leukemia inhibitory factor can mediate Ras\/Raf\/MEK\/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells","volume":"297","author":"Arthan","year":"2010","journal-title":"Cancer Letters"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0185","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.1073\/pnas.141224398","article-title":"Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK\u2013ERK independent mechanism","volume":"98","author":"Chen","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0190","doi-asserted-by":"crossref","first-page":"20801","DOI":"10.1074\/jbc.270.35.20801","article-title":"Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin","volume":"270","author":"Lazar","year":"1995","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0195","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.immuni.2005.08.013","article-title":"The role of erk1 and erk2 in multiple stages of T cell development","volume":"23","author":"Fischer","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0200","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.molcel.2010.02.020","article-title":"ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events","volume":"38","author":"Shin","year":"2010","journal-title":"Molecular Cell"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0205","doi-asserted-by":"crossref","first-page":"36570","DOI":"10.1074\/jbc.M204751200","article-title":"Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells","volume":"277","author":"Lin","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.cgt.7700416","article-title":"Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor","volume":"9","author":"Eder","year":"2002","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0215","first-page":"1008","article-title":"Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells","volume":"62","author":"Zegarra-Moro","year":"2002","journal-title":"Cancer Research"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0220","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1158\/1535-7163.MCT-04-0313","article-title":"Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer","volume":"4","author":"Liao","year":"2005","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0225","doi-asserted-by":"crossref","first-page":"7201","DOI":"10.1038\/onc.2008.320","article-title":"Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer","volume":"27","author":"Rodriguez-Gonzalez","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0230","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ijc.2910570319","article-title":"Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells","volume":"57","author":"Wu","year":"1994","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0235","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-08-3795","article-title":"A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth","volume":"69","author":"Guo","year":"2009","journal-title":"Cancer Research"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0240","first-page":"6606","article-title":"Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line","volume":"62","author":"Tepper","year":"2002","journal-title":"Cancer Research"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0245","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1093\/emboj\/cdf406","article-title":"Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase","volume":"21","author":"Lin","year":"2002","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0250","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1210\/me.2007-0481","article-title":"Target gene specific regulation of androgen receptor activity by p42\/p44 MAPK","volume":"22","author":"Agoulnik","year":"2008","journal-title":"Molecular Endocrinology (Baltimore, Md)"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0255","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14756360802166921","article-title":"Inhibition of rat liver cathepsins B and L by the peptide aldehyde benzyloxycarbonyl-leucyl-leucyl-leucinal and its analogues","volume":"24","author":"Ito","year":"2009","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0260","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/oxfordjournals.jbchem.a021280","article-title":"Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine","volume":"119","author":"Tsubuki","year":"1996","journal-title":"Journal of Biochemistry"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0265","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/(SICI)1097-4644(19990315)72:4<458::AID-JCB2>3.0.CO;2-C","article-title":"Raf-1-induced cell cycle arrest in LNCaP human prostate cancer cells","volume":"72","author":"Ravi","year":"1999","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0270","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/cdd.2010.20","article-title":"Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1\/2, c-jun\/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest","volume":"17","author":"Chan","year":"2010","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0275","first-page":"217","article-title":"Constitutive activation of MAPK\/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2","volume":"30","author":"Moro","year":"2007","journal-title":"International Journal of Oncology"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0280","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1101\/gad.12.19.3008","article-title":"Premature senescence involving p53 and p16 is activated in response to constitutive MEK\/MAPK mitogenic signaling","volume":"12","author":"Lin","year":"1998","journal-title":"Genes & Development"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0285","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature03890","article-title":"BRAFE600-associated senescence-like cell cycle arrest of human naevi","volume":"436","author":"Michaloglou","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0290","first-page":"79","article-title":"GDNF-induced leukemia inhibitory factor can mediate differentiation via the MEK\/ERK pathway in pheochromocytoma cells derived from nf1-heterozygous knockout mice","volume":"303","author":"Park","year":"2005","journal-title":"Experimental Cell Research"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0295","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1074\/jbc.M410542200","article-title":"IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor\/JAK\/STAT pathway in medullary thyroid carcinoma cells","volume":"280","author":"Kim","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.yexcr.2011.08.008_bb0300","doi-asserted-by":"crossref","first-page":"e3949","DOI":"10.1371\/journal.pone.0003949","article-title":"BRAF activation initiates but does not maintain invasive prostate adenocarcinoma","volume":"3","author":"Jeong","year":"2008","journal-title":"PloS one"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482711003314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482711003314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:04:45Z","timestamp":1588809885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482711003314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":60,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0014482711003314"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2011.08.008","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}